This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Rhode Island Hospital, University Health Network. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 116 
1 out of 312 
Years Active: 2017
Title: The Innovations of Benjamin G. Neel in Cancer Treatment
Introduction: Benjamin G. Neel is a notable inventor based in Toronto, Canada, recognized for his contributions to cancer treatment through innovations in biochemical research. With one patent to his name, he has made significant strides in the medical field, particularly in developing methods for tumor treatment.
Latest Patents: Neel’s patent, entitled “Hedgehog Pathway Inhibition for Cartilage Tumor and Metachondromatosis Treatment,” addresses a crucial need in oncology. This patent describes a method for preventing, slowing, or blocking the formation of osseous tumors such as exostoses or enchondromas. The technique involves administering a hedgehog pathway inhibitor, such as a Smoothened inhibitor, to an animal that requires treatment, showcasing an innovative approach to managing cartilage-related tumors.
Career Highlights: Throughout his career, Benjamin G. Neel has held esteemed positions in prominent institutions. He has been affiliated with Rhode Island Hospital and the University Health Network, where he has contributed to advanced research and clinical applications in biology and medicine. His extensive background in these organizations has played a significant role in the development of his patented methodologies.
Collaborations: Neel has worked collaboratively with many professionals in the field, notably with his coworker Wentian Yang. This partnership reflects a shared commitment to research and innovation, driving forward advancements that could have a profound impact on treatment options in oncology.
Conclusion: Benjamin G. Neel represents a dedicated inventor whose work has the potential to influence the lives of many patients suffering from cartilage tumors. His innovative approach to utilizing hedgehog pathway inhibition underscores the importance of collaborative research in the development of effective treatment strategies. Through his patent and career contributions, Neel continues to be at the forefront of medical innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile